RAAS TRIPLE-A Trademark

Trademark Overview


On Wednesday, December 19, 2018, a trademark application was filed for RAAS TRIPLE-A with the United States Patent and Trademark Office. The USPTO has given the RAAS TRIPLE-A trademark a serial number of 79256903. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2020. This trademark is owned by ATTOQUANT DIAGNOSTICS GMBH. The RAAS TRIPLE-A trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Downloadable computer software, application software, mobile application software, software development tools in the nature of computer software, database software in the nature of computer software for use in database management, all aforementioned goods downloadable and related to the medical field, namely, for researching diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Diagnostic agents for pharmaceutical purposes containing chemical preparations, biochemical agents, buffers, and diagnostic reagents, also in the form of kits, for medical purposes in the field of treating diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Chemical, biochemical and biotechnological products, namely, chemical, biochemical and biotechnological agents used for non-medical purposes, namely, agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; chemical preparations, namely, chemical preparations for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; biochemical agents, namely, biochemical agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; buffers, namely, buffers for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system

Medical services, medical care, medical testing in the nature of medical diagnostic testing; providing information in the field of medical information, namely, in the fields of diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Medical and scientific research and analysis services in the nature of quality measurement and analysis for medical practices, and software design and development concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of researching, diagnosing, preventing, combating, treating, and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
raas triple-a

General Information


Serial Number79256903
Word MarkRAAS TRIPLE-A
Filing DateWednesday, December 19, 2018
Status700 - REGISTERED
Status DateTuesday, February 25, 2020
Registration Number5993170
Registration DateTuesday, February 25, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements


Goods and ServicesDownloadable computer software, application software, mobile application software, software development tools in the nature of computer software, database software in the nature of computer software for use in database management, all aforementioned goods downloadable and related to the medical field, namely, for researching diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Goods and ServicesDiagnostic agents for pharmaceutical purposes containing chemical preparations, biochemical agents, buffers, and diagnostic reagents, also in the form of kits, for medical purposes in the field of treating diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemical, biochemical and biotechnological products, namely, chemical, biochemical and biotechnological agents used for non-medical purposes, namely, agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; chemical preparations, namely, chemical preparations for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; biochemical agents, namely, biochemical agents for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system; buffers, namely, buffers for quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system
Goods and ServicesMedical services, medical care, medical testing in the nature of medical diagnostic testing; providing information in the field of medical information, namely, in the fields of diagnosing, preventing, combating, treating and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism
Disclaimer with Predetermined Text"RAAS"
Goods and ServicesMedical and scientific research and analysis services in the nature of quality measurement and analysis for medical practices, and software design and development concerning quantifying and analyzing peptides, enzymes, hormones and metabolites involved in the renin-angiotensin-aldosterone system in the field of researching, diagnosing, preventing, combating, treating, and monitoring the treatment of diseases related to the renin-angiotensin-aldosterone system, including cardiovascular disorders, in particular hypertension and primary aldosteronism

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2019
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 24, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameATTOQUANT DIAGNOSTICS GMBH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressAT

Party NameATTOQUANT DIAGNOSTICS GMBH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAT

Party NameATTOQUANT DIAGNOSTICS GMBH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAT

Trademark Events


Event DateEvent Description
Saturday, November 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 26, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 17, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 25, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 25, 2020FINAL DISPOSITION PROCESSED
Monday, May 25, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 25, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, November 3, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, November 3, 2019EXAMINER'S AMENDMENT ENTERED
Sunday, November 3, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, November 3, 2019EXAMINERS AMENDMENT E-MAILED
Sunday, November 3, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 17, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 17, 2019FINAL REFUSAL E-MAILED
Tuesday, September 17, 2019FINAL REFUSAL WRITTEN
Wednesday, August 14, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 14, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 14, 2019ASSIGNED TO LIE
Monday, August 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 8, 2019REFUSAL PROCESSED BY IB
Wednesday, May 22, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 22, 2019REFUSAL PROCESSED BY MPU
Tuesday, April 30, 2019APPLICATION FILING RECEIPT MAILED
Friday, April 26, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 25, 2019NON-FINAL ACTION WRITTEN
Wednesday, April 24, 2019ASSIGNED TO EXAMINER
Wednesday, April 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 18, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB